LUNA LABS USA LLC — Department of Defense SBIR Phase II: RESEARCH AND DEVELOPMENT DHA PHASE II SBIR FOR PROJECT TITLED, FIELD-DEPLOYABLE NEUROPROTE
LUNA LABS USA LLC — SBIR Phase II award from Department of Defense.
Summary
Luna Labs USA LLC received nearly $1.3 million from the Defense Health Agency to develop portable neuroprotective liposomes for treating traumatic brain injury. This Phase II SBIR project creates a field-ready medical solution to protect and treat brain injuries in military settings.
- Amount
- $1,299,998
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- VA
- Period
- 2026-04-13 → 2028-08-12
Technology domains
Description
RESEARCH AND DEVELOPMENT DHA PHASE II SBIR FOR PROJECT TITLED, FIELD-DEPLOYABLE NEUROPROTECTIVE LIPOSOMES FOR THE TARGETED TREATMENT OF TRAUMATIC BRAIN INJURY